Apogee Therapeutics Inc.’s recently made public that its Chief Medical Officer Dambkowski Carl unloaded Company’s shares for reported $0.32 million on Sep 04 ’24. In the deal valued at $47.56 per share,6,665 shares were sold. As a result of this transaction, Dambkowski Carl now holds 280,793 shares worth roughly $ 13.34 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, HENDERSON MICHAEL THOMAS sold 40,000 shares, generating $1,904,841 in total proceeds. Upon selling the shares at $47.62, the Chief Executive Officer now owns 1,394,487 shares.
Before that, HENDERSON MICHAEL THOMAS bought 40,000 shares. Apogee Therapeutics Inc. shares valued at $1,904,848 were divested by the Officer at a price of $47.62 per share.
BofA Securities initiated its Apogee Therapeutics Inc. [APGE] rating to a Buy in a research note published on May 10, 2024; the price target was $80. A number of analysts have revised their coverage, including BTIG Research’s analysts, who began to cover the stock in mid December with a ‘”a Buy”‘ rating. Wedbush began covering APGE with “an Outperform” recommendation on August 08, 2023. TD Cowen started covering the stock on August 08, 2023. It rated APGE as “an Outperform”.
Price Performance Review of APGE
On Monday, Apogee Therapeutics Inc. [NASDAQ:APGE] saw its stock jump 0.55% to $47.51. Over the last five days, the stock has lost -7.15%. Apogee Therapeutics Inc. shares have risen nearly 70.04% since the year began. Nevertheless, the stocks have risen 101.14% over the past one year. While a 52-week high of $72.29 was reached on 03/13/24, a 52-week low of $14.19 was recorded on 01/08/24. SMA at 50 days reached $45.76, while 200 days put it at $42.87.
Levels Of Support And Resistance For APGE Stock
The 24-hour chart illustrates a support level at 46.55, which if violated will result in even more drops to 45.59. On the upside, there is a resistance level at 49.06. A further resistance level may holdings at 50.61. The Relative Strength Index (RSI) on the 14-day chart is 51.45, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.61, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 74.55%. Stochastics %K at 37.42% indicates the stock is a holding.
How much short interest is there in Apogee Therapeutics Inc.?
A steep rise in short interest was recorded in Apogee Therapeutics Inc. stocks on 2024-08-15, dropping by -0.43 million shares to a total of 8.19 million shares. Yahoo Finance data shows the prior-month short interest on 2024-07-15 was 8.61 million shares. There was a decline of -5.21%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on August 08, 2023 when Stifel began covering the stock and recommended ‘”a Buy”‘ rating along with a $34 price target.
